Companies: 10,795·Total market cap: $144.5T
Curaleaf Holdings, Inc.

Curaleaf Holdings, Inc.

CURA.TOTSXHealthcare● Active
$16.21
+$1.00(+6.57%)
Market Cap$3.8B
P/E Ratio—
52W High$16.92
52W Low$0.99
ForecastMarket CapPE Ratio

Curaleaf Holdings, Inc.（CURA.TO）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

cura.to · 股价预测 · 7 位分析师（近3月）· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 7 位华尔街分析师

SellBuy

Buy

7 位分析师

共识

评级分布

Strong Buy
0
Buy
5
Hold
2
Sell
0
Strong Sell
0
合计: 7 · 买入占比: 71.4%

12 个月目标价

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $16.21

Curaleaf Holdings, Inc.（CURA.TO）的分析师共识为 Buy，基于过去 3 个月内 7 位华尔街分析师的评级。CURA.TO 的 12 个月平均目标价为 $0.00，相对当前价 $16.21 代表 +0.0% 的潜在上行空间。

短期股价预测

Bull

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-09$16.56↑ 2.13%

1-day model range: $16.4–$16.71. Peak: $16.71 (+2.13%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$11-33.1%
2028$9-46.4%
2029$8-52.8%
2030$7-56.2%
2031—-58.1%
Confidence:Medium

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

BULLISH

Based on 14 technical indicators

93%7%0%
13Buy
1Neutral
0Sell
RSI (14)63.2Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · CURA.TO · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$15.13BUY
MA 10$14.58BUY
MA 20$14.77BUY
MA 50$12.91BUY
MA 100$11.35BUY
MA 200$11.45BUY
Current $CURA.TO · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$15.23BUY
EMA 10$14.87BUY
EMA 20$14.53BUY
EMA 50$13.34BUY
EMA 100$12.20BUY
EMA 200$11.09BUY
Current $CURA.TO · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
Needham2024-08-08
Maintains
Buy→Buy
Needham2024-05-10
Maintains
Buy→Buy
Wedbush2024-03-08
Maintains
Outperform→Outperform
Craig-Hallum2024-03-07
Maintains
Hold→Hold
Needham2024-03-07
Maintains
Buy→Buy
Needham2023-08-10
Maintains
Buy→Buy
Benchmark2023-05-19
Downgrade ↓
Buy→Hold
Wedbush2023-05-19
Maintains
Outperform→Outperform
Needham2023-05-18
Maintains
Buy→Buy
Needham2023-05-02
Maintains
Buy→Buy

Wall Street analysts have recently issued updated ratings on Curaleaf Holdings, Inc. (CURA.TO) stock. Of the recent 36 rating actions, 1 were upgrades and 1 were downgrades. 7 analysts currently cover CURA.TO.

分析师推荐趋势

Buy ratings1 → 1
Hold ratings0 → 0
Sell ratings0 → 0

CURA.TO analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$1.3B

↓ 15.8% YoY

Revenue Next Year

$1.4B

↑ 8.1% YoY

EPS This Year

$-0.09

EPS Next Year

$-0.17

↑ 91.1% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast CURA.TO EPS of $-0.09 for the current fiscal year, based on estimates from 2 analysts. The CURA.TO revenue forecast is $1.3B for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

CURA.TO 股价预测由两类独立数据源支撑：来自 7 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CURA.TO 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Buy。

CURA.TO 的短期预测（明日）为 $16.56（+2.13%）。 CURA.TO 对 2027 年的股价预测均值为 $11。 CURA.TO 对 2030 年的预测区间为 $6–$8。

Curaleaf Holdings, Inc. 在 TSX 上市，代码 CURA.TO。CURA.TO 在 2027 年的整体展望偏积极，在覆盖分析师中约 71% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

相关页面

盈利营收市盈率财务报表市值内幕交易股息价格历史

常见问题

CURA.TO 预测 · 8 个问题

根据 7 位华尔街分析师，CURA.TO 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $16.21，隐含约 +0.0% 的上行空间。

CURA.TO 目标价CURA.TO 分析师目标价CURA.TO 12个月目标价目标价 CURA.TO

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.